Loading clinical trials...
Loading clinical trials...
The primary objective is to demonstrate safety and tolerability of switching patients with Restless Legs Syndrome (RLS) from an oral dopamine agonist to rotigotine. As a secondary objective, the inve...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
John Winkelman, MD, PhD
Collaborators
NCT07001891 · Restless Legs Syndrome
NCT06684782 · Restless Legs Syndrome
NCT05908214 · Stroke, Cramp, and more
NCT05321355 · Sleep Disorder, Sleep Disorder Parasomnia, and more
NCT02670161 · Brain Tumors, Epilepsy, and more
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions